SCHEMBL29758558

SCHEMBL29758558

C[C@H]1C[C@@]2(CN1)Cc1cc(C3CC3)ncc1O2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31059164 1.00 — —
SCHEMBL23304722 1.00 — —
SCHEMBL31059133 0.83 CHRNA7 (0.30) —
SCHEMBL23304906 0.83 CHRNA7 (0.30) —
SCHEMBL31059143 0.82 HTR2C (0.30) —
SCHEMBL23304784 0.82 HTR2C (0.30) —
SCHEMBL23304814 0.81 HCAR3 (0.33) —
SCHEMBL31059148 0.80 CHRNB2 (0.36) —
SCHEMBL23304941 0.80 — —
SCHEMBL23304851 0.80 CHRNB2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4051682-A1 SPIROCYCLIC O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS Biogen MA Inc. (US) 2022-09-07 — — EP disclosed
CN-114929709-A Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors 比奥根MA公司 2022-08-19 — — CN disclosed
Send feedback